
BMS and Pfizer Launch Direct-to-Patient Eliquis® Option
A New Approach to Affordability and Access The BMS (Bristol Myers Squibb) -Pfizer Alliance has announced the launch of a new direct-to-patient program for Eliquis® (apixaban), a widely prescribed anticoagulant medication. This initiative, delivered through the Alliance’s Eliquis 360 Support…












